trending Market Intelligence /marketintelligence/en/news-insights/trending/KWsTeCgtC_ptW-CZ6pXpfg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Sinovac seeks China FDA approval for pneumonia vaccine

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sinovac seeks China FDA approval for pneumonia vaccine

Sinovac Biotech Ltd. filed an application seeking approval for its lung infection vaccine from the China Food and Drug Administration.

The vaccine will be used to prevent streptococcus pneumoniae infections, such as pneumonia and septicemia, among adults aged 65 or older and children older than two years with serious long-term health problems.

The submission is supported by a phase 3 clinical trial.